BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1987
Size (employees)
200 (est)
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

CTO
Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
William E. Brown

William E. Brown

VP, Business Development

Biolase Office Locations

Biolase has offices in Irvine, Miami, Denver, Seattle and in 13 other locations
Irvine, US (HQ)
4 Cromwell

Biolase Data and Metrics

Biolase Financial Metrics

Biolase's revenue was reported to be $51.8 m in 2016 which is a 7% increase from the previous period.
$, USD

Revenue (Y, 2016)

51.8 m

Revenue growth (Y, 2015 - Y, 2016), %

7%

Gross profit (Y, 2016)

20.3 m

Gross profit margin (Y, 2016), %

39%

Net income (Y, 2016)

(15.4 m)

EBIT (Y, 2016)

(15 m)

Market capitalization (23-Jun-2017)

63.6 m

Closing share price (23-Jun-2017)

1

Cash (31-Dec-2016)

8.9 m
Biolase's current market capitalization is $63.6 m.
$, USDFY, 2013Y, 2014Y, 2015Y, 2016

Revenue

56.4 m47.7 m48.5 m51.8 m

Revenue growth, %

(16%)2%7%

Cost of goods sold

34.9 m29.5 m32.5 m31.5 m

Gross profit

21.5 m18.2 m16 m20.3 m

Gross profit Margin, %

38%38%33%39%

Operating expense total

32.5 m36.1 m35.9 m35.3 m

EBIT

(11 m)(17.9 m)(19.9 m)(15 m)

EBIT margin, %

(19%)(38%)(41%)(29%)

Interest expense

600 k458 k74 k74 k

Interest income

74 k74 k

Income tax expense

(164 k)112 k178 k151 k

Net Income

(11.5 m)(18.9 m)(20.3 m)(15.4 m)
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.4 m31.6 m11.7 m8.9 m

Inventories

1.9 m1.7 m1.4 m1.5 m

Current Assets

25.9 m54.8 m34.8 m34 m

PP&E

1.8 m1.3 m3.7 m4.5 m

Goodwill

2.9 m2.9 m2.9 m2.9 m

Total Assets

31 m59.4 m42.3 m41.9 m

Accounts Payable

8.6 m8.4 m6 m9.1 m

Current Liabilities

21.9 m16.2 m15.1 m18 m

Additional Paid-in Capital

148.9 m185.2 m188.6 m201.2 m

Retained Earnings

(123.8 m)(142.7 m)(163 m)(178.3 m)

Total Equity

42.1 m24.9 m22.1 m

Financial Leverage

1.4 x1.7 x1.9 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(11.5 m)(18.9 m)(20.3 m)(15.4 m)

Depreciation and Amortization

601 k696 k880 k1 m

Accounts Receivable

264 k826 k(52 k)(644 k)

Inventories

56 k(21 k)(65 k)79 k

Cash From Operating Activities

(1.1 m)

Purchases of PP&E

(198 k)(1.4 m)

Cash From Investing Activities

(685 k)(197 k)(1.8 m)(1.4 m)

Interest Paid

220 k148 k4 k4 k

Income Taxes Paid

47 k52 k57 k76 k
Y, 2016

Financial Leverage

1.9 x

Biolase Market Value History

Biolase Online and Social Media Presence

Biolase Company Life and Culture

You may also be interested in